Morana Jovan-embiricos - Net Worth and Insider Trading
Morana Jovan-embiricos Net Worth
The estimated net worth of Morana Jovan-embiricos is at least $109 Million dollars as of 2024-11-13. Morana Jovan-embiricos is the Director, 10% Owner of Cullinan Therapeutics Inc and owns about 6,139,339 shares of Cullinan Therapeutics Inc (CGEM) stock worth over $98 Million. Morana Jovan-embiricos is the Director of AlloVir Inc and owns about 18,380,807 shares of AlloVir Inc (ALVR) stock worth over $10 Million. Morana Jovan-embiricos is also the 10% Owner of TCR2 Therapeutics Inc and owns about 330,238 shares of TCR2 Therapeutics Inc (TCRR) stock worth over $488,752. Details can be seen in Morana Jovan-embiricos's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Morana Jovan-embiricos has not made any transactions after 2021-11-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Morana Jovan-embiricos
Morana Jovan-embiricos Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Morana Jovan-embiricos owns 4 companies in total, including AlloVir Inc (ALVR) , TCR2 Therapeutics Inc (TCRR) , and Radius Health Inc (RDUS) among others .
Click here to see the complete history of Morana Jovan-embiricos’s form 4 insider trades.
Insider Ownership Summary of Morana Jovan-embiricos
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ALVR | AlloVir Inc | 2021-11-10 | director & 10 percent owner |
| TCRR | TCR2 Therapeutics Inc | 2019-12-19 | director & 10 percent owner |
| RDUS | Radius Health Inc | 2013-04-23 | director & 10 percent owner |
 | | 2021-01-12 | director & 10 percent owner |
Morana Jovan-embiricos Latest Holdings Summary
Morana Jovan-embiricos currently owns a total of 3 stocks. Among these stocks, Morana Jovan-embiricos owns 6,139,339 shares of Cullinan Therapeutics Inc (CGEM) as of January 12, 2021, with a value of $98 Million and a weighting of 90.4%. Morana Jovan-embiricos owns 18,380,807 shares of AlloVir Inc (ALVR) as of November 10, 2021, with a value of $10 Million and a weighting of 9.15%. Morana Jovan-embiricos also owns 330,238 shares of TCR2 Therapeutics Inc (TCRR) as of December 19, 2019, with a value of $488,752 and a weighting of 0.45%.
Latest Holdings of Morana Jovan-embiricos
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CGEM | Cullinan Therapeutics Inc | 2021-01-12 | 6,139,339 | 16.02 | 98,352,211 |
| ALVR | AlloVir Inc | 2021-11-10 | 18,380,807 | 0.54 | 9,953,207 |
| TCRR | TCR2 Therapeutics Inc | 2019-12-19 | 330,238 | 1.48 | 488,752 |
Holding Weightings of Morana Jovan-embiricos
Morana Jovan-embiricos Form 4 Trading Tracker
According to the SEC Form 4 filings, Morana Jovan-embiricos has made a total of 1 transactions in Cullinan Therapeutics Inc (CGEM) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Cullinan Therapeutics Inc is the acquisition of 200,000 shares on January 12, 2021, which cost Morana Jovan-embiricos around $4 Million.
According to the SEC Form 4 filings, Morana Jovan-embiricos has made a total of 5 transactions in AlloVir Inc (ALVR) over the past 5 years, including 1 buys and 4 sells. The most-recent trade in AlloVir Inc is the sale of 800 shares on November 10, 2021, which brought Morana Jovan-embiricos around $19,816.
According to the SEC Form 4 filings, Morana Jovan-embiricos has made a total of 2 transactions in TCR2 Therapeutics Inc (TCRR) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in TCR2 Therapeutics Inc is the sale of 44,856 shares on December 19, 2019, which brought Morana Jovan-embiricos around $740,573.
Insider Trading History of Morana Jovan-embiricos
- 1
Morana Jovan-embiricos Trading Performance
GuruFocus tracks the stock performance after each of Morana Jovan-embiricos's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Morana Jovan-embiricos is 0.58%. GuruFocus also compares Morana Jovan-embiricos's trading performance to market benchmark return within the same time period. The performance of stocks bought by Morana Jovan-embiricos within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Morana Jovan-embiricos's insider trading performs compared to the benchmark.
Performance of Morana Jovan-embiricos
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 23.33 | | | | | |
| Relative Return to S&P 500(%) | 19.9 | | | | | |
Morana Jovan-embiricos Ownership Network
Ownership Network List of Morana Jovan-embiricos
Ownership Network Relation of Morana Jovan-embiricos
Morana Jovan-embiricos Owned Company Details
What does AlloVir Inc do?
Who are the key executives at AlloVir Inc?
Morana Jovan-embiricos is the director & 10 percent owner of AlloVir Inc. Other key executives at AlloVir Inc include director & 10 percent owner & See Remarks Vikas Sinha , General Counsel Edward Miller , and Chief Accounting Officer Brett R Hagen .
AlloVir Inc (ALVR) Insider Trades Summary
Over the past 18 months, Morana Jovan-embiricos made no insider transaction in AlloVir Inc (ALVR). Other recent insider transactions involving AlloVir Inc (ALVR) include a net sale of 193,383 shares made by Diana Brainard , a net sale of 65,497 shares made by Brett R Hagen , and a net sale of 82,092 shares made by Vikas Sinha .
In summary, during the past 3 months, insiders sold 50,935 shares of AlloVir Inc (ALVR) in total and bought 0 shares, with a net sale of 50,935 shares. During the past 18 months, 364,999 shares of AlloVir Inc (ALVR) were sold and 2,930,870 shares were bought by its insiders, resulting in a net purchase of 2,565,871 shares.
AlloVir Inc (ALVR)'s detailed insider trading history can be found in Insider Trading Tracker table.
AlloVir Inc Insider Transactions
Morana Jovan-embiricos Mailing Address
Above is the net worth, insider trading, and ownership report for Morana Jovan-embiricos. You might contact Morana Jovan-embiricos via mailing address: C/o Radius Health, Inc., 201 Broadway, 6th Floor, Boston Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
